| J3262 | Injection, tocilizumab, 1 mg | 27,500 | $10 | $137.5K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 3,750 | $30 | $127.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,920 | $30 | $101.9K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,450 | $30 | $83.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 2,550 | $10 | $25.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 150 | $120 | $17.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 260 | $60 | $15.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 90 | $100 | $9.6K |
| 95004 | The provider performs a percutaneous test with allergenic extracts to determine which substances (allergens) trigger an allergic reaction in the patient. | 3,090 | $1 | $9.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $140 | $6.6K |